← Back to Browse
ProductIT Systems and IT Solutions

Diabetes and Coronary Heart Disease Risk Assessment Platform

China

Multi-omics technology platform for precision prediction and diagnosis of diabetes with cardiovascular disease. Enables genetic risk stratification and clinical decision support for high-risk populations.

Manufactured by

Shenzhen Create Medical Technology Co., Ltd.

China

Shenzhen Create Medical Technology Co., Ltd. manufactures breath diagnostic devices for detecting conditions including H. pylori infection (13C/14C breath tests), gastrointestinal disorders (hydrogen/methane analyzers), airway inflammation (NO analyzers), and halitosis (VSC analyzers). The company also produces non-invasive diabetes screening equipment using AGE detection technology and AI-assisted medical examination systems. Products are exported to over 20 countries.

View profile & products →

© 2026 Suplivia · Home · Browse Products